The small molecule inhibitor WZ-3146 targets KIF4A, suppressing glioma cell proliferation and inducing apoptosis in vitro via Caspase-3 activation, positioning it as a potential candidate for clinical application [8]. This evidence concerns the gene CASP3 and glioma.